![](/img/cover-not-exists.png)
THU0238 Tofacitinib, an Oral Janus Kinase Inhibitor: Safety Comparison in Patients with Rheumatoid Arthritis and an Inadequate Response to Nonbiologic or Biologic Disease-Modifying Anti-Rheumatic Drugs
Burmester, G., Charles-Schoemann, C., Isaacs, J., Hendrikx, T., Kwok, K., Zwillich, S. H., Riese, R.Volume:
72
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2013-eular.766
Date:
June, 2013
File:
PDF, 342 KB
english, 2013